The need for cell and biotherapy donors is rising. To help meet this demand, blood centers are working to transition regular blood donors to become cell and biotherapy donors. Human subject protection is an important aspect for the donations. In this session some of the ethical challenges related to this recruitment and process will be presented and discussed. Topics include biotherapy donor informed consent, payment and frequency of donation. An ethicist will lead this discussion for a robust question and answer period.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Identify key informed consent issues such as sharing with the donor what happens with the cells collected, when this is of a proprietary nature.
Recognize the challenges in explaining and justifying why these donors are paid versus other blood donors. Will we lose blood donors?
Examine and describe the concerns for repeat biotherapy donations.
MD, MBA, MSEd,
University Hospitals, Samaritan Medical Center and Case Western
All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM21-26: Ethics of Engaging Blood Donors for Cell Therapy (Biotherapy) Collections Evaluation